Rapid multiplex diagnostic test for simultaneous detection of influenza A/B, RSV, and SARS-CoV-2 from respiratory specimens. Delivers results in minutes using immunochromatographic technology, enabling fast clinical decision-making in emergency and primary care settings.
Manufactured by
Suwon-si, South Korea
SD BIOSENSOR is an in-vitro diagnostics company that contributes to improving the quality of life by quickly and accurately diagnosing diseases under the slogan Beginning of all things that protect lives . We have provided various diagnostic platforms to the IVD industry through the constant technological innovation such as POC Molecular Diagnostics, Fluorescent Immunoassay, Immunochromatography, BGMS and CGMS. The headquarters of SD BIOSENSOR is located in Korea and, the subsidiaries are placed in the Brazil, Panama, Colombia, India, Indonesia, Germany, Italy and Spain.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
FlashDx Inc.
United States · 2 relevant products
ProGnosis Biotech S.A.
Greece · 1 relevant product
Vitrosens Biyoteknoloji Anonim Sirketi
Türkiye · 2 relevant products
Innovita (Tang Shan) Biological Technology Co.,Ltd.
China · 4 relevant products
Genesystem Co., Ltd.
South Korea · 1 relevant product
Aceso Laboratories, Inc.
United States · 1 relevant product
Reagen Inc.
United States · 3 relevant products
Goldsite Diagnostics Inc.
China · 2 relevant products
Qingdao Hightop Biotech Co., Ltd
China · 2 relevant products
Hangzhou AllTest Biotech Co.,Ltd
China · 6 relevant products
65 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 119 closest product alternatives
FlashDx Inc. · United States
Rapid molecular diagnostic test for simultaneous detection of SARS-CoV-2, Influenza A, Influenza B, and RSV using sample-to-answer syndromic testing technology. Enables near-patient testing with fast turnaround for respiratory pathogen identification, supporting clinical decision-making and patient management in healthcare settings.
ProGnosis Biotech S.A. · Greece
Rapid antigen test for simultaneous detection of influenza A & B and COVID-19 using advanced antigen-antibody technology. Delivers fast, reliable results for respiratory infection screening in clinical settings. ELISA and lateral flow formats available for point-of-care and laboratory use.
Vitrosens Biyoteknoloji Anonim Sirketi · Türkiye
Rapid antigen/antibody test for respiratory disease detection with fast, reliable results for clinical screening.
Vitrosens Biyoteknoloji Anonim Sirketi · Türkiye
Multiplex rapid diagnostic test for simultaneous detection of SARS-CoV-2, influenza A/B, RSV, adenovirus, and human metapneumovirus from respiratory specimens. Delivers results in 5–10 minutes using immunofluorescence or rapid immunochromatographic methods, enabling point-of-care screening and differential diagnosis of respiratory infections.
Innovita (Tang Shan) Biological Technology Co.,Ltd. · China
A multiplexed rapid diagnostic test for the simultaneous detection and differentiation of Influenza A, Influenza B, and SARS-CoV-2 antigens. The test enables comprehensive respiratory pathogen screening in a single assay.
Genesystem Co., Ltd. · South Korea
Multiplex molecular diagnostic test for simultaneous detection of SARS-CoV-2, influenza, and respiratory syncytial virus. Provides rapid and precise results using biochip-based technology.
Aceso Laboratories, Inc. · United States
Multiplex rapid antigen test simultaneously detecting Adenovirus, Human Parainfluenza Virus, RSV, COVID-19, Metapneumovirus, Rhinovirus, Influenza B, Influenza A, and Human Metapneumovirus from respiratory specimens. Designed for point-of-care and clinical laboratory use to enable rapid differential diagnosis of respiratory infections.
Reagen Inc. · United States
Multiplex rapid test kit for simultaneous detection and differentiation of COVID-19, Influenza A, Influenza B, and RSV in a single test strip. Provides results in under 10 minutes for respiratory pathogen screening.
Goldsite Diagnostics Inc. · China
Multiplex antigen test simultaneously detecting SARS-CoV-2, Influenza A/B, and RSV from a single patient sample. Enables rapid point-of-care diagnosis of common respiratory pathogens for clinical and emergency settings.
Qingdao Hightop Biotech Co., Ltd · China
Rapid antigen test for simultaneous detection of SARS-CoV-2 and Influenza A+B from respiratory specimens. Delivers results within 15-20 minutes, enabling quick triage and differential diagnosis in clinical and point-of-care settings. Colloidal gold immunochromatographic technology provides high sensitivity and specificity for acute respiratory infection management.
Hangzhou AllTest Biotech Co.,Ltd · China
A multiplex rapid antigen test for simultaneous detection of five respiratory pathogens including SARS-CoV-2, influenza, RSV, adenovirus, and M. pneumoniae. This comprehensive test supports rapid differential diagnosis of respiratory infections.
SureScreen Diagnostics Limited · United Kingdom
A rapid diagnostic test that delivers simultaneous results for both COVID-19 and influenza viruses, helping clinicians make informed decisions and patients receive appropriate care quickly.
107 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products